CoChat

A Novel Feed-Forward Loop between ARIH2 E3-Ligase and PABPN1 Regulates Aging-Associated Muscle Degeneration

Raz, Vered, Buijze, Hellen, Raz, Yotam, Verwey, Nisha, Anvar, Seyed Yahya, Aartsma-Rus, Annemieke, van der Maarel, Silvère M. · 2014 · The American Journal of Pathology
Cited by 37

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2013.12.011

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Sandri, 2008, Signaling in muscle atrophy and hypertrophy, Physiology (Bethesda), 23, 160, 10.1152/physiol.00041.2007 · DOI · Paper page
  2. Lindner, 2009, Protein aggregation as a paradigm of aging, Biochim Biophys Acta, 1790, 980, 10.1016/j.bbagen.2009.06.005 · DOI
  3. Brais, 2009, Oculopharyngeal muscular dystrophy: a polyalanine myopathy, Curr Neurol Neurosci Rep, 9, 76, 10.1007/s11910-009-0012-y · DOI
  4. Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
  5. Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
  6. Raz, 2013, 191st ENMC International Workshop: recent advances in oculopharyngeal muscular dystrophy research: from bench to bedside 8-10 June 2012, Naarden, The Netherlands, Neuromuscul Disord, 23, 516, 10.1016/j.nmd.2013.03.001 · DOI
  7. Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum Mol Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
  8. Anvar, 2013, A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging, Aging (Albany NY), 5, 412, 10.18632/aging.100567 · DOI
  9. Simonelig, 2012, PABPN1 shuts down alternative poly(A) sites, Cell Res, 22, 1419, 10.1038/cr.2012.86 · DOI
  10. Benoit, 2005, An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila, Dev Cell, 9, 511, 10.1016/j.devcel.2005.09.002 · DOI
  11. Jenal, 2012, The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites, Cell, 149, 538, 10.1016/j.cell.2012.03.022 · DOI · Paper page
  12. de Klerk, 2012, Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation, Nucleic Acids Res, 40, 9089, 10.1093/nar/gks655 · DOI · Paper page
  13. Beaulieu, 2012, Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding protein nuclear 1, PLoS Genet, 8, 15, 10.1371/journal.pgen.1003078 · DOI · Paper page
  14. Raz, 2011, Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein, Am J Pathol, 179, 1988, 10.1016/j.ajpath.2011.06.044 · DOI · Paper page
  15. Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet Muscle, 1, 15, 10.1186/2044-5040-1-15 · DOI
  16. Raz, 2013, Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy, BMC Neurol, 13, 1471, 10.1186/1471-2377-13-70 · DOI
  17. Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum Mol Genet, 19, 2191, 10.1093/hmg/ddq098 · DOI
  18. Zhu, 2007, Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies, Aging Cell, 6, 515, 10.1111/j.1474-9726.2007.00306.x · DOI · Paper page
  19. Raz, 2011, Reversible aggregation of PABPN1 pre-inclusion structures, Nucleus, 2, 208, 10.4161/nucl.2.3.15736 · DOI · Paper page
  20. Raz, 2006, Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells, J Cell Sci, 119, 4247, 10.1242/jcs.03180 · DOI
  21. Aartsma-Rus, 2009, Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms, Mol Ther, 17, 548, 10.1038/mt.2008.205 · DOI
  22. Aartsma-Rus, 2012, Overview on DMD exon skipping, Methods Mol Biol, 867, 97, 10.1007/978-1-61779-767-5_7 · DOI
  23. Aartsma-Rus, 2004, Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells, Gene Ther, 11, 1391, 10.1038/sj.gt.3302313 · DOI
  24. Passtoors, 2012, Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R, PLoS One, 7, e27759, 10.1371/journal.pone.0027759 · DOI · Paper page
  25. Verheesen, 2006, Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody, Hum Mol Genet, 15, 105, 10.1093/hmg/ddi432 · DOI
  26. Marzani, 2005, Human muscle aging: ROS-mediated alterations in rectus abdominis and vastus lateralis muscles, Exp Gerontol, 40, 959, 10.1016/j.exger.2005.08.010 · DOI
  27. Abu-Baker, 2003, Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy, Hum Mol Genet, 12, 2609, 10.1093/hmg/ddg293 · DOI
  28. Périé, 2006, Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation, Neuromuscul Disord, 16, 770, 10.1016/j.nmd.2006.07.022 · DOI
  29. Zhan, 2007, Temporal and spatial transcriptional profiles of aging in Drosophila melanogaster, Genome Res, 17, 1236, 10.1101/gr.6216607 · DOI
  30. Calado, 2000, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum Mol Genet, 9, 2321, 10.1093/oxfordjournals.hmg.a018924 · DOI · Paper page
  31. Ciechanover, 2003, The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg, Neuron, 40, 427, 10.1016/S0896-6273(03)00606-8 · DOI · Paper page
  32. Bennett, 2005, Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation, Mol Cell, 17, 351, 10.1016/j.molcel.2004.12.021 · DOI · Paper page
  33. Bence, 2001, Impairment of the ubiquitin-proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552 · DOI · Paper page
  34. Sandri, 2004, Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy, Cell, 117, 399, 10.1016/S0092-8674(04)00400-3 · DOI · Paper page
  35. Eisenhaber, 2007, The ring between ring fingers (RBR) protein family, Genome Biol, 8, 209, 10.1186/gb-2007-8-3-209 · DOI · Paper page
  36. Bennett, 2010, RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform, Annu Rev Pharmacol Toxicol, 50, 259, 10.1146/annurev.pharmtox.010909.105654 · DOI · Paper page
  37. Goemans, 2011, Systemic administration of PRO051 in Duchenne's muscular dystrophy, N Engl J Med, 364, 1513, 10.1056/NEJMoa1011367 · DOI · Paper page
  38. Vickers, 2001, Fully modified 2′ MOE oligonucleotides redirect polyadenylation, Nucleic Acids Res, 29, 1293, 10.1093/nar/29.6.1293 · DOI · Paper page

Metadata

Authors
Raz, V., Buijze, H., Raz, Y., Verwey, N., Anvar, S. Y., Aartsma-Rus, A., & van der Maarel, S. M.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2014-04
Volume
184
Issue
4
Pages
1119-1131
ISSN
0002-9440
Cited by
37
References
10
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.